I've been really sceptical of this business, largely because of TheDocYard's huge valuation and cash burn (and very little revenue and low-to-no revenue growth); and then combined business capitalising R&D in the 'Investing' part of the cash flows which when combined showed a quarterly burn...
...however, it looks like they have turned things around. The cash is finally starting to be positive, so looks promising! Well done to the Ansarada team.
Ann: Quarterly Activities Report/FY21 Preliminary Results, page-4
Add to My Watchlist
What is My Watchlist?